The in vivo study also verified the inhibitory effects of RPL35A knockdown on GC tumorigenesis.<h4>Conclusions</h4>The above mentioned results indicated that the knockdown of RPL35A might be a considerable therapeutic strategy for the treatment of gastric cancer. Here, RPL35A is linked to gastric cancer.